Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party
Bone Marrow Transplant. 2023 Jan;58(1):119-120.
doi: 10.1038/s41409-022-01855-8.
1 Department of Hematology and Oncology, Ospedale Civile "Santo Spirito", Pescara, Italy. [email protected].
2 EBMT Statistical Unit, Leiden, The Netherlands.
3 Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer, & Centre de Recherches en Cancérologie de Marseille (CRCM), Inserm UMR 1068, Université d'Aix-Marseille, Marseille, France.
4 Medicana International Hospital Istanbul, Istanbul, Turkey.
5 Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
6 Istituto Clinico Humanitas, Milano, Italy.
7 Anadolu Medical Center Hospital, Kocaeli, Turkey.
8 Servicio de Hematología Hospital G. Universitario Gregorio Marañon, Instituto de Investigación sanitaria Gregorio Marañon, Department of Medicine Universidad Complutense, Madrid, Spain.
9 Hospital U. Marqués de Valdecilla, Santander, Spain.
10 RM Gorbacheva Research Institute, Pavlov University, St, Petersburg, Russia.
11 Demiroglu Bilim University Istanbul Florence Nightingale Hospital Istanbul, Istanbul, Turkey.
12 Hospital Universitario Reina Sofia. IMIBIC. University of Cordoba, Cordoba, Spain.
13 Institute of Hematology, Centro Ricerche Emato-Oncologiche, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy.
14 Department of Hematology and Oncology, Ospedale Civile "Santo Spirito", Pescara, Italy.
15 EBMT Leiden Study Unit, Leiden, The Netherlands.
16 Leiden University Medical Center, Leiden, The Netherlands.
17 San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation unit, Milan, Italy.
18 Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer & Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT, 1409, Marseille, France.